1. Home
  2. EZPW vs STOK Comparison

EZPW vs STOK Comparison

Compare EZPW & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZCORP Inc. Non Voting

EZPW

EZCORP Inc. Non Voting

HOLD

Current Price

$30.21

Market Cap

2.0B

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$28.91

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZPW
STOK
Founded
1989
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
EZPW
STOK
Price
$30.21
$28.91
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$30.67
$39.20
AVG Volume (30 Days)
856.7K
591.1K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
29.09
92.73
EPS
1.17
N/A
Revenue
$747,954,000.00
$184,420,000.00
Revenue This Year
$25.40
N/A
Revenue Next Year
$11.33
$77.49
P/E Ratio
$24.93
N/A
Revenue Growth
2.39
404.50
52 Week Low
$13.96
$12.75
52 Week High
$37.13
$40.22

Technical Indicators

Market Signals
Indicator
EZPW
STOK
Relative Strength Index (RSI) 41.85 43.99
Support Level $27.86 $27.97
Resistance Level $36.88 $33.51
Average True Range (ATR) 1.66 1.46
MACD -0.34 0.02
Stochastic Oscillator 26.59 52.24

Price Performance

Historical Comparison
EZPW
STOK

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: